Related Experiment Video
Updated: May 20, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway
Hailin Tang1, Zeyou Wang, Xiaoping Liu
1Cancer Research Institute, Central South University, Changsha, Hunan, China.
Abstract:
Leucine-rich repeat (LRR) genes encode transmembrane proteins that are essential for normal brain development and are often dysregulated in central nervous system tumors. Leucine-rich repeat C4 (LRRC4) is a member of the LRR protein superfamily and specifically expressed in brain tissue. Importantly it acts as a tumor suppressor in the pathogenesis of malignant gliomas. However, the molecular mechanisms by which LRRC4 regulates glioma tumorigenesis are largely unknown. In this report, we found that miR-185 is markedly upregulated by LRRC4. We also found that miR-185 was downregulated in glioma, and overexpression of miR-185 inhibited glioma cell invasion. Low expressions of LRRC4 and miR-185 were associated with a poor outcome in glioma patients. Further investigation revealed that LRRC4 mediated its tumor suppressor function by regulating miR-185 targets CDC42 and RhoA. LRRC4 overexpression inhibited glioma cell invasion through miR-185-mediated CDC42 and RhoA direct regulation and VEGFA indirect regulation. Together, our findings suggest that the altered expression of the tumor suppressor LRRC4 may be an important event that leads to the dysregulation of miR-185 in human gliomas. LRRC4 and miR-185 may also be good prognostic markers and therapeutic targets in glioma.
Insights
Leucine-rich repeat C4 (LRRC4) suppresses glioma by regulating miR-185. Lower levels of LRRC4 and miR-185 correlate with poor glioma patient outcomes, suggesting their potential as prognostic markers.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genetics
Background:
- Leucine-rich repeat (LRR) genes are crucial for brain development and implicated in central nervous system tumors.
- Leucine-rich repeat C4 (LRRC4) is a brain-specific LRR protein functioning as a tumor suppressor in malignant gliomas.
- The precise molecular mechanisms of LRRC4's tumor suppressor activity in glioma remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying LRRC4's tumor suppressor role in glioma.
- To investigate the relationship between LRRC4, miR-185, and glioma cell invasion.
- To evaluate LRRC4 and miR-185 as potential prognostic markers for glioma patients.
Main Methods:
- Analysis of LRRC4-mediated upregulation of miR-185.
- Assessment of miR-185 expression levels in glioma tissues.
- Evaluation of the impact of miR-185 overexpression on glioma cell invasion.
- Correlation analysis of LRRC4 and miR-185 expression with patient outcomes.
- Investigation of LRRC4's regulation of miR-185 targets (CDC42, RhoA) and VEGFA.
Main Results:
- LRRC4 significantly upregulates miR-185 expression.
- miR-185 is downregulated in glioma, and its overexpression inhibits glioma cell invasion.
- Low expression of both LRRC4 and miR-185 is associated with poor prognosis in glioma patients.
- LRRC4 exerts its tumor suppressor function by regulating miR-185 targets CDC42 and RhoA, and indirectly affecting VEGFA.
Conclusions:
- Altered LRRC4 expression contributes to miR-185 dysregulation in human gliomas.
- The LRRC4/miR-185 pathway plays a critical role in glioma tumorigenesis.
- LRRC4 and miR-185 show promise as prognostic biomarkers and therapeutic targets for glioma.
Related Concept Videos
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Experimental RNAi
lncRNA - Long Non-coding RNAs
